Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma (Q38575418)

4 September 2017

title

Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma (English)

1 reference

4 September 2017

1 reference

el-Galley RE

1

1 reference

4 September 2017

Petros JA

2

1 reference

4 September 2017

Sanders WH

3

1 reference

4 September 2017

Keane TE

4

1 reference

4 September 2017

Galloway NT

5

1 reference

4 September 2017

Cooner WH

6

1 reference

4 September 2017

Graham SD Jr

7

1 reference

4 September 2017

language of work or name

English

0 references

publication date

1 August 1995

1 reference

4 September 2017

1 reference

4 September 2017

volume

46

1 reference

4 September 2017

issue

2

1 reference

4 September 2017

page(s)

200-204

1 reference

4 September 2017

cites work

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Prostate-specific antigen: concepts for staging prostate cancer and monitoring response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Prostate-Specific Antigen, Digital Rectal Examination, and Transrectal Ultrasonography: Their Roles in Diagnosing Early Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

The Inability of Prostate Specific Antigen Index to Enhance the Predictive Value of Prostate Specific Antigen in the Diagnosis of Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Screening for Prostatic Carcinoma with Prostate Specific Antigen: Results of the Second Year

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Clinical application of transrectal ultrasonography and prostate specific antigen in the search for prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Prostate Specific Antigen Levels in Men Older than 50 Years without Clinical Evidence of Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980194-0

7 January 2021

10.1016/S0090-4295(99)80194-0

Identifiers

DOI

1 reference

4 September 2017

1 reference